New research questioned old assumptions https://www.medpagetoday.com/neurology/painmanagement/119247 In January 2025, we reported that some adverse events associated with gabapentin (Neurontin) may have been overestimated. Since then, new risks related to gabapentin emerged and prescribing continued to rise. Here’s what we learned about gabapentin in 2025. Often championed as a safer alternative to opioids and prescribed off-label for chronic […]
Filed under: General Problems | Leave a Comment »

















